All of the latest Insights
We are excited to announce a new chapter for Visible Analytics as we take our HTA, analytical and value communications expertise into a broader market access space. We have been acquired by Newmarket Strategy, a leading consultancy specialising in market access, health system policy, and strategic advisory services across the life sciences and health technology sectors.
What can we learn from the recent NICE appraisal of bew groundbreaking gene therapy for sickle cell disorder (SCD), and how can we use these insights to better shape reimbursement and market access for patients with SCD and other underserved or rare conditions?
Budapest | Leicester | Oxford | Reading
Company registration number: 11202459
VAT number: 320382734
